Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 4

Results For "Pharma"

5284 News Found

Aurobindo Pharma wins key FDA nod for $138M US cough drug market entry
Drug Approval | April 20, 2026

Aurobindo Pharma wins key FDA nod for $138M US cough drug market entry

The drug is designed to provide temporary relief from cough caused by throat and bronchial irritation


Department of Pharmaceuticals seeks proposals for SPEL study to strengthen logistics ecosystem
Supply Chain | April 18, 2026

Department of Pharmaceuticals seeks proposals for SPEL study to strengthen logistics ecosystem

Bidding window open till May 15; study to map costs and bottlenecks across pharma supply chains


Indian Pharmacopoeia 2026 highlights need for stronger drug standards and global alignment
Policy | April 18, 2026

Indian Pharmacopoeia 2026 highlights need for stronger drug standards and global alignment

Experts highlighted that robust pharmacopoeial frameworks are essential for maintaining the quality, safety and efficacy of medicines


Piramal Pharma, Ajinomoto Bio-Pharma collaborate to accelerate ADC development
Biopharma | April 17, 2026

Piramal Pharma, Ajinomoto Bio-Pharma collaborate to accelerate ADC development

Collaboration integrates AJICAP™ technology with global manufacturing capabilities to streamline antibody-drug conjugate pipelines


NIFTY Pharma shows stable trend amid cautious market sentiment
News | April 17, 2026

NIFTY Pharma shows stable trend amid cautious market sentiment

Muted movement reflects consolidation phase as investors await earnings triggers


OpenAI unveils GPT-Rosalind to accelerate drug discovery for pharma giants
Digitisation | April 17, 2026

OpenAI unveils GPT-Rosalind to accelerate drug discovery for pharma giants

New purpose-built AI model targets faster R&D cycles and deeper scientific insights across life sciences


Moberg Pharma reports 2025 annual results, maintains strong cash position
News | April 17, 2026

Moberg Pharma reports 2025 annual results, maintains strong cash position

The company reported net revenue of SEK 13.5 million for the full year 2025


NIPER Mohali, Novartis Healthcare sign pact to boost pharma R&D innovation
R&D | April 16, 2026

NIPER Mohali, Novartis Healthcare sign pact to boost pharma R&D innovation

The grant backed by Novartis to strengthen academia-industry collaboration across all seven NIPERs


India Pharma 2026 concludes with strong call for funding, infrastructure and speed to power innovation
Policy | April 15, 2026

India Pharma 2026 concludes with strong call for funding, infrastructure and speed to power innovation

The ninth edition of the event brought together over 800 delegates, more than 60 national and international speakers, and 20+ partner organisations across 10 sessions